All-cause mortality after major gastrointestinal bleeding among patients receiving direct oral anticoagulants: a protocol for a systematic review and meta-analysis.

Chornenki, Nicholas L J; Tritschler, Tobias; Stucki, Fabian; Odabashian, Roupen; Leentjens, Jenneke; Khan, Faizan; Ly, Valentina; Siegal, Deborah M (2022). All-cause mortality after major gastrointestinal bleeding among patients receiving direct oral anticoagulants: a protocol for a systematic review and meta-analysis. Systematic Reviews, 11(1), p. 269. BioMed Central 10.1186/s13643-022-02146-5

[img]
Preview
Text
s13643-022-02146-5.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (813kB) | Preview

BACKGROUND

Gastrointestinal (GI) bleeding represents the single most frequent site of anticoagulant-related bleeding. Adverse outcomes after major GI bleeding including mortality are not well characterized and, as a result, may be underappreciated in clinical practice. We aim to conduct a systematic review and meta-analysis of the risk for 30-day all-cause mortality after major GI bleeding among patients receiving DOACs.

METHODS

Electronic databases including MEDLINE, EMBASE, and Cochrane CENTRAL will be systematically searched to identify randomized controlled trials and prospective and retrospective cohort studies reporting 30-day all-cause mortality in adults with DOAC-related major GI bleeding. At least two investigators will independently perform study selection, risk of bias assessment, and data extraction. The proportion of deaths following a major GI event relative to the number of major GI bleeding events will be calculated for each individual study, and results across studies will be pooled using random-effects meta-analysis. We will assess risk of bias using criteria proposed by the GRADE group for prognostic studies.

DISCUSSION

The findings of this systematic review and meta-analysis will provide clinicians and patients with estimates of mortality after the most common major bleeding event to support shared decision making about anticoagulation management.

TRIAL REGISTRATION

PROSPERO CRD42022295815.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of General Internal Medicine (DAIM) > Clinic of General Internal Medicine
04 Faculty of Medicine > Department of General Internal Medicine (DAIM) > Clinic of General Internal Medicine > Centre of Competence for General Internal Medicine

UniBE Contributor:

Tritschler, Tobias, Stucki, Fabian

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2046-4053

Publisher:

BioMed Central

Language:

English

Submitter:

Pubmed Import

Date Deposited:

19 Dec 2022 11:58

Last Modified:

25 Dec 2022 02:12

Publisher DOI:

10.1186/s13643-022-02146-5

PubMed ID:

36514164

Uncontrolled Keywords:

Anticoagulation Bleeding Direct oral anticoagulants Mortality

BORIS DOI:

10.48350/175935

URI:

https://boris.unibe.ch/id/eprint/175935

Actions (login required)

Edit item Edit item
Provide Feedback